San Diego – October 19, 2026 -- Capricor Therapeutics (NASDAQ: CAPR) will present 24-month skeletal muscle and cardiac data from its Phase 3 HOPE-3 trial of Deramiocel in Duchenne muscular dystrophy (DMD) at the World Muscle Society Congress, weeks ahead of an FDA PDUFA target action date of November 22, 2026.

The 31st Annual Congress (WMS 2026) runs September 29 to October 3, 2026, in Hiroshima, Japan. Capricor will deliver one late-breaking poster and one oral presentation on Deramiocel, plus two preclinical posters from its StealthX exosome platform.

Seongnam – October 19, 2026 -- NTL HEALTHCARE drew more than 200 representatives of distributors, healthcare institutions and policy organizations to its booth at WHX Johannesburg 2026 (October 6-8) and supplied its CerviCARE AI cervical screening system to Zimbabwe during the show.

Singapore – October 18, 2026 -- HistoIndex and Singapore's Agency for Science, Technology and Research (A*STAR) have signed a Memorandum of Understanding to jointly run preclinical evaluation and characterization of therapeutic candidates for fibrotic diseases, including cancer-associated fibrosis.

Barcelona – October 18, 2026 -- Young adults who received antibiotics from childhood onward had 1.5 times the odds of irritable bowel syndrome (IBS) at age 24 (95% CI 1.0–2.2), according to a study presented at UEG Week 2026.

Study tracks 2,853 Swedish participants from age 9–11

Researchers analysed data from 2,853 participants in the Swedish BAMSE birth cohort. Antibiotic prescriptions came from the Swedish Prescribed Drug Register, covering 2005, when participants were aged 9–11, until one year before IBS was assessed at age 24.

Indianapolis – October 18, 2026 -- Eli Lilly and Company (NYSE: LLY) will present first Phase 1 data for its investigational FRα-targeting antibody-drug conjugate sofetabart mipitecan (Sofe-M) in platinum-sensitive ovarian cancer (PSOC) at the European Society for Medical Oncology (ESMO) Congress, October 23–27 in Madrid, alongside updated data across lung, thyroid and breast cancer programs.

Valby, Denmark – October 18, 2026 -- H. Lundbeck A/S plans to install former Novo Nordisk CEO Lars Fruergaard Jørgensen as Chair of its Board after the 2027 Annual General Meeting (AGM), succeeding Dorothea Wenzel, who will step down at that meeting.

Menlo Park, Calif. – October 18, 2026 -- Antheia has received a conditional commitment from the U.S. Department of War's Office of Strategic Capital (OSC) for a direct, long-term loan of up to $80 million to expand domestic production of critical pharmaceutical ingredients.

The loan, together with additional private capital, would fund Antheia's U.S. manufacturing strategy. The company's advanced biosynthesis platform is the technology behind the planned onshoring effort.

United States – October 17, 2026 -- Digital Diagnostics says its LumineticsCore system avoided 91% of unnecessary specialty visits in a pivotal clinical trial and cut time-to-follow-up for positive patients from 60 days to 5 days. The company made the claims in AdvaMed's "The Insight Series: AI & Digital Health," speaking through Jacque Engle, Vice President of Marketing & Communication, and Juli Goldstein, Vice President of Government Affairs & Market Access.

Boston – October 17, 2026 -- AdvaMed will host The MedTech Conference October 18–21 in Boston, with programming across more than seven stages and over 20 focus areas and a keynote panel of three medtech chief executives.

Three medtech CEOs headline the featured keynote discussion

The featured session, "Pulse of Medtech: Where the Industry Is Going Next," brings together Mick Farrell of Resmed, Mike Mahoney of Boston Scientific and Ashley McEvoy of Insulet. John Babitt of EY will moderate.

Boston – October 17, 2026 -- The MedTech Conference, running October 18–21 in Boston, will include 65 early- and mid-stage companies from the 2026 MedTech Innovator cohort, chosen from more than 1,800 applicants, alongside a program that makes digital health a core thread of the event, according to AdvaMed Digital Health Tech's new executive director.